Investment
Features
FeesSafety
Academy
More
Pluang+

Investigation launched into ADMA Biologics over alleged revenue inflation and channel stuffing claims.

Market News
06 Apr 2026
Newsfile Corp
View Source
Bearish
pluang ai news

Levi & Korsinsky has started an investigation into ADMA Biologics following accusations that the company inflated revenue figures through channel stuffing. ADMA reported 51% growth in ASCENIV net revenue for Q4 2025, but a short-seller report claims actual demand is declining, creating a significant discrepancy. The stock dropped sharply after the report's release. Investors who suffered losses may seek recovery under federal securities laws as the investigation unfolds.

More News (ADMA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App